EpiBiome is a venture-backed precision microbiome engineering company with the mission of developing effective and sustainable FDA-approved therapies to combat infectious disease in humans and in agriculture without the use of small-molecule antibiotics. Its first product will address bovine mastitis, an inflammation of the udder tissue in dairy cows, usually caused by bacterial infection.
Market
Healthcare and Agriculture
Location
South San Francisco,
California,
USA
Coinvestors
Alexandria Venture Investments, China Rock Capital, Illumina For Startups, Matrix Capital Management, SV Tech Ventures